Agri-Pulse reports the Food and Drug Administration has for the first time approved an intentional genomic alteration, or IGA, in animals that can be used for both food and human therapeutics. The IGA is in what are called GalSafe pigs, bred to eliminate alpha-gal sugar on the surface of the pigs’ cells.
The article references Scott Commins, MD, PhD, associate professor of medicine in the division of rheumatology, allergy and immunology, an expert on the alpha-gal syndrome which is known as mammalian meat allergy.
“In the U.S., the Lone Star Tick appears to be the primary vector of sensitization,” the article reports from Commin’s website.